352 related articles for article (PubMed ID: 20010815)
1. Cdk2 suppresses cellular senescence induced by the c-myc oncogene.
Campaner S; Doni M; Hydbring P; Verrecchia A; Bianchi L; Sardella D; Schleker T; Perna D; Tronnersjö S; Murga M; Fernandez-Capetillo O; Barbacid M; Larsson LG; Amati B
Nat Cell Biol; 2010 Jan; 12(1):54-9; sup pp 1-14. PubMed ID: 20010815
[TBL] [Abstract][Full Text] [Related]
2. Myc, Cdk2 and cellular senescence: Old players, new game.
Campaner S; Doni M; Verrecchia A; Fagà G; Bianchi L; Amati B
Cell Cycle; 2010 Sep; 9(18):3655-61. PubMed ID: 20818171
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inactivation of CDK2 inhibits MYC/BCL-XL-driven leukemia in vivo through induction of cellular senescence.
Bazzar W; Bocci M; Hejll E; Högqvist Tabor V; Hydbring P; Grandien A; Alzrigat M; Larsson LG
Cell Cycle; 2021 Jan; 20(1):23-38. PubMed ID: 33356836
[TBL] [Abstract][Full Text] [Related]
4. Cdk2: a key regulator of the senescence control function of Myc.
Hydbring P; Larsson LG
Aging (Albany NY); 2010 Apr; 2(4):244-50. PubMed ID: 20445224
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation.
Hydbring P; Bahram F; Su Y; Tronnersjö S; Högstrand K; von der Lehr N; Sharifi HR; Lilischkis R; Hein N; Wu S; Vervoorts J; Henriksson M; Grandien A; Lüscher B; Larsson LG
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):58-63. PubMed ID: 19966300
[TBL] [Abstract][Full Text] [Related]
6. AP4 is required for mitogen- and c-MYC-induced cell cycle progression.
Jackstadt R; Hermeking H
Oncotarget; 2014 Sep; 5(17):7316-27. PubMed ID: 25261373
[TBL] [Abstract][Full Text] [Related]
7. CDK2 is required by MYC to induce apoptosis.
Deb-Basu D; Aleem E; Kaldis P; Felsher DW
Cell Cycle; 2006 Jun; 5(12):1342-7. PubMed ID: 16760655
[TBL] [Abstract][Full Text] [Related]
8. MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts.
Zhang F; Zakaria SM; Högqvist Tabor V; Singh M; Tronnersjö S; Goodwin J; Selivanova G; Bartek J; Castell A; Larsson LG
Cell Cycle; 2018; 17(24):2697-2715. PubMed ID: 30526305
[TBL] [Abstract][Full Text] [Related]
9. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
10. Tipping the balance: Cdk2 enables Myc to suppress senescence.
Hydbring P; Larsson LG
Cancer Res; 2010 Sep; 70(17):6687-91. PubMed ID: 20713526
[TBL] [Abstract][Full Text] [Related]
11. Myc and a Cdk2 senescence switch.
van Riggelen J; Felsher DW
Nat Cell Biol; 2010 Jan; 12(1):7-9. PubMed ID: 20027199
[TBL] [Abstract][Full Text] [Related]
12. Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc.
D'Artista L; Bisso A; Piontini A; Doni M; Verrecchia A; Kress TR; Morelli MJ; Del Sal G; Amati B; Campaner S
Oncotarget; 2016 Apr; 7(16):21786-98. PubMed ID: 26943576
[TBL] [Abstract][Full Text] [Related]
13. Cdk2 and Cdk4 activities are dispensable for tumorigenesis caused by the loss of p53.
Padmakumar VC; Aleem E; Berthet C; Hilton MB; Kaldis P
Mol Cell Biol; 2009 May; 29(10):2582-93. PubMed ID: 19307310
[TBL] [Abstract][Full Text] [Related]
14. Cyclin-dependent kinase 2 is dispensable for normal centrosome duplication but required for oncogene-induced centrosome overduplication.
Duensing A; Liu Y; Tseng M; Malumbres M; Barbacid M; Duensing S
Oncogene; 2006 May; 25(20):2943-9. PubMed ID: 16331279
[TBL] [Abstract][Full Text] [Related]
15. CDK2 transcriptional repression is an essential effector in p53-dependent cellular senescence-implications for therapeutic intervention.
Zalzali H; Nasr B; Harajly M; Basma H; Ghamloush F; Ghayad S; Ghanem N; Evan GI; Saab R
Mol Cancer Res; 2015 Jan; 13(1):29-40. PubMed ID: 25149358
[TBL] [Abstract][Full Text] [Related]
16. Critical roles of Cyclin D1 in mouse embryonic fibroblast cell reprogramming.
Oh HR; Kim J; Kim J
FEBS J; 2016 Dec; 283(24):4549-4568. PubMed ID: 27790870
[TBL] [Abstract][Full Text] [Related]
17. Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5.
Tago K; Funakoshi-Tago M; Itoh H; Furukawa Y; Kikuchi J; Kato T; Suzuki K; Yanagisawa K
Oncogene; 2015 Jan; 34(3):314-22. PubMed ID: 24469041
[TBL] [Abstract][Full Text] [Related]
18. The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathway.
Martinelli P; Bonetti P; Sironi C; Pruneri G; Fumagalli C; Raviele PR; Volorio S; Pileri S; Chiarle R; McDuff FK; Tusi BK; Turner SD; Inghirami G; Pelicci PG; Colombo E
Blood; 2011 Jun; 117(24):6617-26. PubMed ID: 21518927
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo.
Takeuchi S; Takahashi A; Motoi N; Yoshimoto S; Tajima T; Yamakoshi K; Hirao A; Yanagi S; Fukami K; Ishikawa Y; Sone S; Hara E; Ohtani N
Cancer Res; 2010 Nov; 70(22):9381-90. PubMed ID: 21062974
[TBL] [Abstract][Full Text] [Related]
20. Collaboration of MYC and RUNX2 in lymphoma simulates T-cell receptor signaling and attenuates p53 pathway activity.
Hay J; Gilroy K; Huser C; Kilbey A; Mcdonald A; MacCallum A; Holroyd A; Cameron E; Neil JC
J Cell Biochem; 2019 Oct; 120(10):18332-18345. PubMed ID: 31257681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
